{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:09:31Z","timestamp":1776128971445,"version":"3.50.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["614739-A_HERO"],"award-info":[{"award-number":["614739-A_HERO"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004700","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T17:46:03Z","timestamp":1462556763000},"page":"e0004700","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacokinetic Study of Praziquantel Enantiomers and Its Main Metabolite R-trans-4-OH-PZQ in Plasma, Blood and Dried Blood Spots in Opisthorchis viverrini-Infected Patients"],"prefix":"10.1371","volume":"10","author":[{"given":"Isabel","family":"Meister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Huwyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Vanobberghen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somphou","family":"Sayasone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.actatropica.2003.02.001","article-title":"Epidemiology of <italic>Opisthorchis viverrini<\/italic>","volume":"88","author":"P Sithithaworn","year":"2003","journal-title":"Acta Trop"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(11)70294-8","article-title":"Global burden of human food-borne trematodiasis: a systematic review and meta-analysis","volume":"12","author":"T F\u00fcrst","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parint.2011.06.015","article-title":"Raw attitudes, wetland cultures, life-cycles: Socio-cultural dynamics relating to <italic>Opisthorchis viverrini<\/italic> in the Mekong Basin","volume":"61","author":"C Grundy-Warr","year":"2012","journal-title":"Parasitol Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0065-308X(10)72011-X","article-title":"Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control","volume":"72","author":"B Sripa","year":"2010","journal-title":"Adv Parasitol"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1093\/cid\/cis528","article-title":"Severe morbidity due to <italic>Opisthorchis viverrini<\/italic> and <italic>Schistosoma mekongi<\/italic> infection in Lao People&apos;s Democratic Republic","volume":"55","author":"S Sayasone","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.actatropica.2003.08.002","article-title":"Pathobiology of opisthorchiasis: an update","volume":"88","author":"B Sripa","year":"2003","journal-title":"Acta Trop"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.actatropica.2003.03.001","article-title":"Clinical manifestation of opisthorchiasis and treatment","volume":"88","author":"E Mairiang","year":"2003","journal-title":"Acta Trop"},{"key":"ref8","unstructured":"World Health Organization. Control of foodborne trematode infections: report of a WHO study group. 1995."},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/AAC.44.10.2903-2904.2000","article-title":"Bioavailability of praziquantel increases with concomitant administration of food","volume":"44","author":"N Castro","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4269\/ajtmh.1994.51.809","article-title":"Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure","volume":"51","author":"MA El Guiniady","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1371\/journal.pntd.0000357","article-title":"Taste, a new incentive to switch to (R)-Praziquantel in schistosomiasis treatment","volume":"3","author":"T Meyer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","author":"P Olliaro","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00931694","article-title":"Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite on <italic>Schistosoma mansoni<\/italic> in vitro","volume":"78","author":"U Staudt","year":"1992","journal-title":"Parasitol Res"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4269\/ajtmh.1991.45.345","article-title":"Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica","volume":"45","author":"MH Wu","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"5\u20136","key":"ref15","first-page":"429","article-title":"Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data","volume":"59","author":"X-Q Li","year":"2003","journal-title":"Eur J of Clin Pharmacol"},{"issue":"1\u20132","key":"ref16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0378-4347(97)00638-5","article-title":"Investigation of the stereoselective metabolism of praziquantel after incubation with rat liver microsomes by capillary electrophoresis and liquid chromatography-mass spectrometry","volume":"708","author":"C Lerch","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0731-7085(01)00417-4","article-title":"Investigation of praziquantel metabolism in isolated rat hepatocytes","volume":"26","author":"H Meier","year":"2001","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molcata.2004.09.015","article-title":"Biomimetic oxidation of praziquantel catalysed by metalloporphyrins","volume":"226","author":"AJB Melo","year":"2005","journal-title":"J Mol Catal"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1128\/AAC.02741-14","article-title":"Activity of praziquantel enantiomers and main metabolites against <italic>Schistosoma mansoni<\/italic>","volume":"58","author":"I Meister","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"ref20","first-page":"717","article-title":"Pharmacokinetics of praziquantel in patients with opisthorchiasis","volume":"24","author":"K Na Bangchang","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2125.2010.03874.x","article-title":"Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity","volume":"71","author":"RM Lima","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00216-011-5161-6","article-title":"Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications","volume":"402","author":"J Deglon","year":"2013","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac303205m","article-title":"Dried blood spots: analysis and applications","volume":"85","author":"PA Demirev","year":"2013","journal-title":"Anal Chem"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"N Spooner","year":"2009","journal-title":"Anal Chem"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4155\/bio.12.321","article-title":"Merck&apos;s perspective on the implementation of dried blood spot technology in clinical drug development\u2014why, when and how","volume":"5","author":"Y Xu","year":"2013","journal-title":"Bioanalysis"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4155\/bio.10.159","article-title":"Pharmacokinetic considerations as to when to use dried blood spot sampling","volume":"2","author":"G Emmons","year":"2010","journal-title":"Bioanalysis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpba.2015.10.011","article-title":"Development and validation of an enantioselective LC-MS\/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spots","volume":"118","author":"I Meister","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"ref28","unstructured":"European Medicines Agency. Guideline on bioanalytical method validation. (also available from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu<\/ext-link>), 2011."},{"key":"ref29","unstructured":"Food and Drug Administration. Draft Guidance for Industry: Bioanalytical Method Validation.(also available from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\" xlink:type=\"simple\">http:\/\/www.fda.gov<\/ext-link>), 2013."},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Y Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/2987937","article-title":"Measurement in medicine: the analysis of method comparison studies","author":"DG Altman","year":"1983","journal-title":"The statistician"},{"issue":"8476","key":"ref32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"327","author":"JM Bland","year":"1986","journal-title":"The Lancet"},{"key":"ref33","first-page":"182","article-title":"Agreed statistics","volume":"116","author":"JM Bland","year":"2012","journal-title":"Measurement method comparison Anesthesiology"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/10543400701329422","article-title":"Agreement between methods of measurement with multiple observations per individual","volume":"17","author":"JM Bland","year":"2007","journal-title":"J Biopharm Stat"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"e1037","DOI":"10.1371\/journal.pntd.0001037","article-title":"Helminth and intestinal protozoa infections, multiparasitism and risk factors in Champasack province, Lao People&apos;s Democratic Republic","volume":"5","author":"S Sayasone","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"e1726","DOI":"10.1371\/journal.pntd.0001726","article-title":"Efficacy of Praziquantel against <italic>Schistosoma mekongi<\/italic> and <italic>Opisthorchis viverrini<\/italic>: A Randomized, Single-Blinded Dose-Comparison Trial","volume":"6","author":"L Lovis","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0169-4758(88)90047-6","article-title":"Altered drug metabolism in parasitic diseases","volume":"4","author":"BL Tekwanl","year":"1988","journal-title":"Parasitol Today"},{"issue":"2\u20133","key":"ref38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(01)00165-6","article-title":"Alteration of drug biotransformation and elimination during infection and inflammation","volume":"92","author":"KW Renton","year":"2001","journal-title":"Pharmacol Ther"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/j.1875-9114.2012.01108.x","article-title":"Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults","volume":"32","author":"MP Pai","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"ref40","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.actatropica.2010.07.006","article-title":"Opisthorchiasis and <italic>Opisthorchis<\/italic>-associated cholangiocarcinoma in Thailand and Laos","volume":"120","author":"B Sripa","year":"2011","journal-title":"Acta Trop"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1371\/journal.pntd.0001165","article-title":"A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg\/kg vs. 60 mg\/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil","volume":"5","author":"PL Olliaro","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1517\/14656566.5.8.1711","article-title":"Chemotherapy for major food-borne trematodes: a review","volume":"5","author":"J Keiser","year":"2004","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/ajcn\/33.4.876","article-title":"Carnitine status in Thai adults","volume":"33","author":"V Tanphaichitr","year":"1980","journal-title":"Am J Clin Nutr"},{"issue":"18","key":"ref44","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.18632\/oncotarget.2378","article-title":"Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment","volume":"5","author":"JT Isaacs","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4155\/bio.14.259","article-title":"Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod","volume":"7","author":"LD Svensson","year":"2015","journal-title":"Bioanalysis"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/AAC.02139-13","article-title":"Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants","volume":"58","author":"M Cohen-Wolkowiez","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:07:11Z","timestamp":1589022431000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004700"}},"subtitle":[],"editor":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004700","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,6]]}}}